| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/17/1997 | US5639455 Immunosuppressant |
| 06/17/1997 | US5639453 Therapeutic uses of IL-3 |
| 06/12/1997 | WO1997020940A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 06/12/1997 | WO1997020927A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |
| 06/12/1997 | WO1997020856A1 ACYLATED ENOL DERIVATIVES OF α-KETOESTERS AND α-KETOAMIDES |
| 06/12/1997 | WO1997020815A1 Compounds |
| 06/12/1997 | WO1997020811A1 Vitamin d analogues |
| 06/12/1997 | WO1997020806A1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
| 06/12/1997 | WO1997020805A1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity |
| 06/12/1997 | WO1997020802A1 Indane dimer compounds and their pharmaceutical use |
| 06/12/1997 | WO1997020576A1 Vaccine compositions for intranasal administration comprising chitosan and use thereof |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | WO1997020570A1 Non-immunogenic and toleragenic platelet and red blood cell compositions |
| 06/12/1997 | WO1997014964A3 Patient-specific immunoadsorbents for extracorporal apheresis and methods of producing said immuno-adsorbers |
| 06/12/1997 | WO1997012963A3 A paf-acetylhydrolase and use in therapy |
| 06/12/1997 | WO1997012035A3 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 06/12/1997 | WO1997011667A3 Therapeutic applications using horse serum |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239868A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 06/12/1997 | CA2239574A1 Non-immunogenic and toleragenic platelet and red blood cell compositions |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | CA2192281A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/11/1997 | EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists |
| 06/11/1997 | EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |
| 06/11/1997 | EP0777736A1 Functional modified hsv1-tk |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777677A1 Methods of identifying compounds useful for treating autoimmune diseases |
| 06/11/1997 | EP0777666A1 Novel substituted piperidines useful for the treatment of allergic diseases |
| 06/11/1997 | EP0777653A1 Dihygropyridine derivatives as bradykinin antagonists |
| 06/11/1997 | EP0777646A1 Metalloproteinase inhibitors |
| 06/11/1997 | EP0777644A1 D-b-lysylmethanediamine derivatives with bacteria, aids virus and tumor cell growth inhibiting activity and preparation thereof |
| 06/11/1997 | EP0777494A1 Human chemokine polypeptides |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777490A1 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 06/11/1997 | EP0777488A1 Composition and method for allogeneic mononuclear cell immunotherapy |
| 06/11/1997 | EP0777482A1 Combined preparation for the therapy of immune diseases |
| 06/11/1997 | EP0777481A1 Use of n-substituted phenothiazines |
| 06/11/1997 | EP0746320A4 Hiv protease inhibitors and intermediates |
| 06/11/1997 | EP0703913B1 Imidazoles as lipoxygenase inhibitors |
| 06/11/1997 | EP0607186B1 Macrophage activating factor from animal vitamin d-binding protein |
| 06/11/1997 | EP0472706B1 Induction of protection against viral infection |
| 06/11/1997 | EP0446315B1 Process for the preparation of pai-2 |
| 06/11/1997 | CN1151699A Health compsn. |
| 06/11/1997 | CN1151697A Anti-hiv triple combination |
| 06/10/1997 | US5637711 Chemical intermediate; 1-epoxidemethyl substituted piperazine ring |
| 06/10/1997 | US5637703 Derivatives of genistein |
| 06/10/1997 | US5637614 Immunomodulator |
| 06/10/1997 | US5637613 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 06/10/1997 | US5637590 Rapamycin amidino carbamates |
| 06/10/1997 | US5637577 Treatment of potozoal diseases |
| 06/10/1997 | US5637571 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis |
| 06/10/1997 | CA2074876C Condensed naphthyridine derivatives |
| 06/05/1997 | WO1997020063A1 THEREAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 |
| 06/05/1997 | WO1997020054A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 06/05/1997 | WO1997019942A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 06/05/1997 | WO1997019692A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/05/1997 | DE19544507A1 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations |
| 06/05/1997 | CA2238944A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/05/1997 | CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant |
| 06/04/1997 | EP0776906A2 Sm-D peptide antigens and their use especially in the diagnosis of systemic lupus erythromatodes |
| 06/04/1997 | EP0776885A1 Diaromatic compounds with an adamantyl group in the ortho position, pharmaceutical and cosmetic compositions containing them and uses |
| 06/04/1997 | EP0776881A1 Bi-aromatic compounds comprising an adamantyl group in para-position, pharmaceutical and cosmetic compositions containing them and their utilization |
| 06/04/1997 | EP0776339A1 Mhc complexes and uses thereof |
| 06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
| 06/04/1997 | EP0776333A1 Peptide antagonist intermediates of neurotensin |
| 06/04/1997 | EP0776332A1 NEW PEPTIDE DERIVATIVES WITH $g(d) OPIOID RECEPTOR ANTAGONIST OR MIXED $g(m) AGONIST/$g(d) ANTAGONIST EFFECTS |
| 06/04/1997 | EP0716658B1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars |
| 06/04/1997 | EP0552269B1 Platelet adhesion inhibitor |
| 06/04/1997 | EP0491829B1 Composition for immune system activation |
| 06/04/1997 | CN1151186A Thymidine kinase mutants |
| 06/04/1997 | CN1151119A Medical use of bromelain |
| 06/04/1997 | CN1151117A Binding of E-selectin, P-selectin or L-selectin to sialyl-Lewis(x) or sialyl-lewis(a) |
| 06/04/1997 | CN1151116A Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 06/04/1997 | CN1035056C Method for preparing cyclic neurokinin A antagonists |
| 06/04/1997 | CN1035054C Novel isoxazolines as antiinflammatory agents |
| 06/03/1997 | US5635524 Cyclization; salt formation; separation; stimulant for beta-adrenergic receptors |
| 06/03/1997 | US5635516 (Thia) cycloalkyl[B]indole compounds as anti-inflammatory agents |
| 06/03/1997 | US5635502 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ACE |
| 06/03/1997 | US5635478 Use of calcitonin gene-related peptide to regulate immune response |
| 06/03/1997 | US5635388 Monoclonal antibody produced by a hybridoma cell binds to the extracellular domain of flk2/flk3 and activates the intracellular tyrosine kinase domain enhancing repopulation of myeloid and lymphoid blood cell lineages with cytokines |
| 06/03/1997 | US5635187 Adding phytogenic compounds to storage solution to increase organ preservation for transplantation |
| 06/03/1997 | US5635186 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 06/03/1997 | CA2077651C Peptides stimulating cytotoxic t cells immune to hiv rt |
| 06/03/1997 | CA2040517C 1,8-naphthyridin-2-one derivatives |
| 05/29/1997 | WO1997019113A2 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 05/29/1997 | WO1997019104A1 Cyclopeptolides |
| 05/29/1997 | WO1997019086A1 Epothilone derivatives, preparation and use |
| 05/29/1997 | WO1997019074A1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018790A2 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 05/29/1997 | WO1997013505A3 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 05/29/1997 | CA2238262A1 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | CA2210705A1 Monoclonal antiidiotypic antibodies (ab2) and their uses |
| 05/28/1997 | EP0775206A1 Dual hybrid system |
| 05/28/1997 | EP0775205A1 Novel cell surface receptor, antibody compositions, and methods of using same |